Keeping up the PACE at the Scottish Medicines Consortium

26 March 2019 - There are many ways that patient centricity could be delivered when doing a health technology assessment. ...

Read more →

Whether the TGA should publish that a prescription medicine is under evaluation

15 February 2019 - The TGA is seeking comments from interested parties on whether or not the TGA should in future ...

Read more →

NICE provides first scientific advice on patient preference study design

14 February 2019 - The NICE Scientific Advice team, working with the Science Policy and Research team at NICE, has provided ...

Read more →

Risk classification of antimicrobials used in animals opens for public consultation

5 February 2019 - EMA has published today for public consultation its updated scientific advice on the categorisation of antimicrobials.  ...

Read more →

Patient groups fail to declare financial interests during NICE assessments

16 January 2019 - Patients’ groups involved in assessing treatments for the NHS often fail to disclose their financial interests, ...

Read more →

Proposal to list a new presentation of raltegravir and amend arrangements for raltegravir and posaconazole

7 December 2018 - PHARMAC is seeking feedback on a multi-product proposal with Merck Sharpe & Dohme.  ...

Read more →

EMA seeks feedback on using registries for regulatory purposes

15 November 2018 - The EMA is seeking feedback on the use of patient disease registries for regulatory purposes.  ...

Read more →

Working with stakeholders to improve availability of medicines in the EU

31 October 2018 - The task force set up by EMA and the Heads of Medicines Agencies on availability of ...

Read more →

The FDA announces Patient Engagement Advisory Committee meeting on utilising real world data from patient-driven platforms that connect and empower patients

21 September 2018 - On 15 November 2018, the FDA’s Patient Engagement Advisory Committee will hold its second public meeting ...

Read more →

Ensuring patient voices are heard: how patients can contribute to the CADTH Symposium

24 August 2018 - This webinar will outline the process for submitting abstracts and offer tips and ideas to increase the ...

Read more →

Post-market review of the use of biologics in the treatment of severe chronic plaque psoriasis

17 August 2018 - The PBAC minutes pertaining to the draft review report for the post-market review of the use of ...

Read more →

Are health apps good for your health? Have your say.

12 July 2018 - The Consumers Health Forum today introduces an innovative online mechanism to gauge community trust in health ...

Read more →

Statement from FDA Commissioner on new agency efforts to advance the patient voice in medical product development and FDA regulatory decision-making

12 June 2018 - Over the past decade, advances in our understanding of the basic biology of serious and life-threatening ...

Read more →

FDA drafts new guidance on formal meetings between FDA, biosimilar sponsors

4 June 2018 - The US FDA has released new draft guidance on formal meetings between biosimilar sponsors and the ...

Read more →

Community voices important to PHARMAC

28 May 2018 - This year, PHARMAC is reviewing the way we seek and incorporate the consumer voice in our ...

Read more →